Similarity-based machine learning methods for predicting drug-target interactions: a brief review
暂无分享,去创建一个
Hao Ding | Ichigaku Takigawa | Hiroshi Mamitsuka | Shanfeng Zhu | Hiroshi Mamitsuka | Ichigaku Takigawa | Shanfeng Zhu | Hao Ding
[1] Yoshihiro Yamanishi,et al. Supervised prediction of drug–target interactions using bipartite local models , 2009, Bioinform..
[2] Roded Sharan,et al. Combining Drug and Gene Similarity Measures for Drug-Target Elucidation , 2011, J. Comput. Biol..
[3] Hiroki Kobayashi,et al. Integrating Statistical Predictions and Experimental Verifications for Enhancing Protein-Chemical Interaction Predictions in Virtual Screening , 2009, PLoS Comput. Biol..
[4] Philippe Sanseau,et al. Editorial: Computational methods for drug repurposing , 2011, Briefings Bioinform..
[5] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[6] Catherine Brooksbank,et al. The European Bioinformatics Institute’s data resources , 2009, Nucleic Acids Res..
[7] Peter B. McGarvey,et al. Infrastructure for the life sciences: design and implementation of the UniProt website , 2009, BMC Bioinformatics.
[8] B. Stockwell. Chemical genetics: ligand-based discovery of gene function , 2000, Nature Reviews Genetics.
[9] Joel Dudley,et al. Exploiting drug-disease relationships for computational drug repositioning , 2011, Briefings Bioinform..
[10] Andreas Bender,et al. From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.
[11] Jean-Philippe Vert,et al. Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..
[12] Xiaobo Zhou,et al. Semi-supervised drug-protein interaction prediction from heterogeneous biological spaces , 2010, BMC Systems Biology.
[13] M S Waterman,et al. Identification of common molecular subsequences. , 1981, Journal of molecular biology.
[14] Jean-Philippe Vert,et al. Supervised reconstruction of biological networks with local models , 2007, ISMB/ECCB.
[15] J. Ballesteros,et al. G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.
[16] John B. O. Mitchell. The Relationship between the Sequence Identities of Alpha Helical Proteins in the PDB and the Molecular Similarities of Their Ligands , 2001, J. Chem. Inf. Comput. Sci..
[17] D. Bojanic,et al. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development. , 2005, Drug discovery today.
[18] Thomas Lengauer,et al. A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.
[19] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[20] Ruth Nussinov,et al. Principles of docking: An overview of search algorithms and a guide to scoring functions , 2002, Proteins.
[21] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[22] Damian Szklarczyk,et al. STITCH 3: zooming in on protein–chemical interactions , 2011, Nucleic Acids Res..
[23] Sanjay Joshua Swamidass,et al. Mining small-molecule screens to repurpose drugs , 2011, Briefings Bioinform..
[24] P. Bork,et al. A side effect resource to capture phenotypic effects of drugs , 2010, Molecular systems biology.
[25] Yoshihiro Yamanishi,et al. Predicting drug side-effect profiles: a chemical fragment-based approach , 2011, BMC Bioinformatics.
[26] M. Moran,et al. Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.
[27] Gregory D. Schuler,et al. Database resources of the National Center for Biotechnology Information: update , 2004, Nucleic acids research.
[28] Brian K. Shoichet,et al. Molecular docking using shape descriptors , 1992 .
[29] S. L. Wong,et al. Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.
[30] Robert B. Russell,et al. SuperTarget and Matador: resources for exploring drug-target relationships , 2007, Nucleic Acids Res..
[31] Yoshihiro Yamanishi,et al. Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..
[32] Daniel R. Caffrey,et al. Structure-based maximal affinity model predicts small-molecule druggability , 2007, Nature Biotechnology.
[33] Chuang Liu,et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference , 2012, PLoS Comput. Biol..
[34] Mehmet Gönen,et al. Predicting drug-target interactions from chemical and genomic kernels using Bayesian matrix factorization , 2012, Bioinform..
[35] Charles J. Manly,et al. The impact of informatics and computational chemistry on synthesis and screening. , 2001, Drug discovery today.
[36] P. Bork,et al. Large‐scale prediction of drug–target relationships , 2008, FEBS letters.
[37] Kara Dolinski,et al. The BioGRID Interaction Database: 2011 update , 2010, Nucleic Acids Res..
[38] Pierre Acklin,et al. Similarity Metrics for Ligands Reflecting the Similarity of the Target Proteins , 2003, J. Chem. Inf. Comput. Sci..
[39] P. Bork,et al. Drug Target Identification Using Side-Effect Similarity , 2008, Science.
[40] S. Haggarty,et al. Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays. , 2003, Chemistry & biology.
[41] Laetitia Martin-Chanas,et al. Identify drug repurposing candidates by mining the Protein Data Bank , 2011, Briefings Bioinform..
[42] M. Kanehisa,et al. Development of a chemical structure comparison method for integrated analysis of chemical and genomic information in the metabolic pathways. , 2003, Journal of the American Chemical Society.
[43] H. Lehrach,et al. A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.
[44] C. Dobson. Chemical space and biology , 2004, Nature.
[45] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[46] K. Tsuda,et al. Mining Significant Substructure Pairs for Interpreting Polypharmacology in Drug-Target Network , 2011, PloS one.
[47] Chih-Jen Lin,et al. LIBSVM: A library for support vector machines , 2011, TIST.
[48] S Garattini,et al. Are me-too drugs justified? , 1997, Journal of nephrology.
[49] Yoshihiro Yamanishi,et al. Prediction of drug–target interaction networks from the integration of chemical and genomic spaces , 2008, ISMB.
[50] Yasubumi Sakakibara,et al. Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..
[51] Xin Chen,et al. DCDB: Drug combination database , 2010, Bioinform..
[52] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[53] Mark Goadrich,et al. The relationship between Precision-Recall and ROC curves , 2006, ICML.
[54] T. Klabunde. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.
[55] Michael J. Keiser,et al. Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.
[56] J. Irwin,et al. Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.
[57] Elena Marchiori,et al. Gaussian interaction profile kernels for predicting drug-target interaction , 2011, Bioinform..
[58] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[59] Stuart L. Schreiber,et al. Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays , 2002, Nature.
[60] Antje Chang,et al. New Developments , 2003 .
[61] H. Yabuuchi,et al. Analysis of multiple compound–protein interactions reveals novel bioactive molecules , 2011, Molecular systems biology.
[62] Kara Dolinski,et al. The BioGRID Interaction Database: 2008 update , 2008, Nucleic Acids Res..
[63] Jean-Philippe Vert,et al. SIRENE: supervised inference of regulatory networks , 2008, ECCB.
[64] P. Bork,et al. Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.
[65] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.
[66] Hiroshi Mamitsuka,et al. A probabilistic model for mining implicit 'chemical compound-gene' relations from literature , 2005, ECCB/JBI.
[67] Andrew L. Hopkins,et al. Drug discovery: Predicting promiscuity , 2009, Nature.
[68] Ioannis Xenarios,et al. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions , 2002, Nucleic Acids Res..